Vir Biotechnology (VIR) Insider Trading & Ownership → What is the 72-Hour Profit Surge? (From DTI) (Ad) Free vir Stock Alerts $7.74 +0.11 (+1.44%) (As of 09:39 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Vir Biotechnology (NASDAQ:VIR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$17.73 M Get VIR Insider Trade Alerts Want to know when executives and insiders are buying or selling Vir Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VIR Insider Buying and Selling by Quarter Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Vir Biotechnology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/3/2024Backer Marianne DeCEOSell72,995$9.46$690,532.70 4/1/2024Ann M HanlyEVPSell2,711$10.05$27,245.55 3/27/2024Sung LeeCFOSell6,008$9.89$59,419.12 2/26/2024George A ScangosDirectorSell17,722$11.65$206,461.30 2/22/2024Ann M HanlyEVPSell12,296$10.05$123,574.80 2/22/2024George A ScangosDirectorSell10,028$10.05$100,781.40 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/20/2024George A ScangosDirectorSell16,872$10.22$172,431.84 2/16/2024George A ScangosDirectorSell10,878$10.24$111,390.72 2/16/2024Phillip PangEVPSell3,321$10.24$34,007.04 6/30/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell700$25.11$17,577.00 6/30/2023Vicki L SatoDirectorSell18,000$24.66$443,880.00 6/28/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell7,010$25.10$175,951.00 6/20/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell9,902$25.18$249,332.36 6/15/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell55,182$25.85$1,426,454.70 6/13/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell106,854$27.09$2,894,674.86 6/7/2023Phillip PangInsiderSell5,000$25.95$129,750.00 6/5/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell5,197$27.32$141,982.04 6/2/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell34,365$27.32$938,851.80 6/1/2023Saira RamasastryDirectorSell3,500$25.67$89,845.00 6/1/2023Steven J RiceInsiderSell2,500$25.67$64,175.00 5/24/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell104,384$26.15$2,729,641.60 5/22/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell91,896$25.72$2,363,565.12 5/19/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell91,651$25.38$2,326,102.38 5/5/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell136$25.10$3,413.60 5/3/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell83,674$25.51$2,134,523.74 5/1/2023Endurance (Cayman) Ltd SvfMajor ShareholderSell3,075$25.30$77,797.50 (Data available from 1/1/2013 forward) VIR Insider Trading Activity - Frequently Asked Questions Who is on Vir Biotechnology's Insider Roster? The list of insiders at Vir Biotechnology includes Ann M Hanly, Backer Marianne De, Charles Elliott Sigal, Endurance (Cayman) Ltd Svf, George A Scangos, Herbert Virgin, Howard Horn, Janet Napolitano, Johanna Friedl-Naderer, Phillip Pang, Robert J More, Saira Ramasastry, Steven J Rice, Sung Lee, Vicki L Sato. Learn more on insiders at VIR. What percentage of Vir Biotechnology stock is owned by insiders? 18.10% of Vir Biotechnology stock is owned by insiders. Learn more on VIR's insider holdings. Which Vir Biotechnology insiders have been buying company stock? The following insider purchased VIR shares in the last 24 months: Charles Elliott Sigal ($126,400.00). How much insider buying is happening at Vir Biotechnology? Insiders have purchased a total of 5,000 VIR shares in the last 24 months for a total of $126,400.00 bought. Which Vir Biotechnology insiders have been selling company stock? The following insiders have sold VIR shares in the last 24 months: Ann M Hanly ($270,420.08), Backer Marianne De ($690,532.70), Endurance (Cayman) Ltd Svf ($82,007,911.45), George A Scangos ($1,674,636.39), Howard Horn ($119,683.52), Johanna Friedl-Naderer ($33,819.24), Phillip Pang ($1,412,724.69), Saira Ramasastry ($280,029.34), Steven J Rice ($114,274.49), Sung Lee ($59,419.12), and Vicki L Sato ($4,731,150.47). How much insider selling is happening at Vir Biotechnology? Insiders have sold a total of 3,521,799 Vir Biotechnology shares in the last 24 months for a total of $91,394,601.49 sold. More Insider Trading Tools from MarketBeat Related Companies: SRRK Insider Selling TARS Insider Selling ADAP Insider Selling KYTX Insider Selling BCRX Insider Selling RLAY Insider Selling FDMT Insider Selling RGNX Insider Selling ADMA Insider Selling CRGX Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:VIR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.